Earnings per Share

12 Months Ended

Dec. 31, 2011

Earnings per Share [Abstract]

Earnings per Share

15.    Earnings per Share

Basic and diluted earnings per share are calculated as follows:

	For the Years Ended December 31,
(In millions)	2011			2010			2009
Numerator:
Net income attributable to Biogen Idec Inc.	$	1,234.4		$	1,005.3		$	970.1
Adjustment for net income allocable to preferred stock		(0.5	)		(2.0	)		(1.7	)
Net income used in calculating basic and diluted earnings per share	$	1,233.9		$	1,003.3		$	968.4
Denominator:
Weighted average number of common shares outstanding		242.4			252.3			287.4
Effect of dilutive securities:
Stock options and employee stock purchase plan		1.0			0.9			0.6
Time-vested restricted stock units		1.3			1.6			1.4
Market stock units		0.3			0.1			—
Performance-vested restricted stock units settled in shares		—			—			0.1
Dilutive potential common shares		2.6			2.6			2.1
Shares used in calculating diluted earnings per share		245.0			254.9			289.5

The following amounts were not included in the calculation of net income per diluted share because their effects were anti-dilutive:

	For the Years Ended December 31,
(In millions)	2011		2010		2009
Numerator:
Net income allocable to preferred stock	$	0.5	$	2.0	$	1.7
Denominator:
Stock options		—		4.6		8.5
Time-vested restricted stock units		—		0.1		2.1
Market stock units		—		—		—
Performance-vested restricted stock units settled in shares		—		—		0.2
Convertible preferred stock		0.1		0.5		0.5
Total		0.1		5.2		11.3

Earnings per share for the years ended December 31, 2011 and 2010 reflects, on a weighted average basis, the repurchase of 6.0 million shares and 40.3 million shares, respectively, of our common stock under our share repurchase authorizations.